| CXCL11 |
CXCL11, ITAC, SCYB11, SCYB9B: Small-inducible cytokine B11 precursor |
IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
0.557 |
Evidence |
|
| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
ERBB4 |
ERBB4, HER4: Receptor tyrosine-protein kinase erbB-4 precursor |
0.557 |
Evidence |
|
| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
EPHA4 |
EPHA4, HEK8, SEK, TYRO1: Ephrin type-A receptor 4 precursor |
0.557 |
Evidence |
|
| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
EPHA1 |
EPHA1, EPH, EPHT, EPHT1: Ephrin type-A receptor 1 precursor |
0.557 |
Evidence |
|
| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
0.557 |
Evidence |
|
| CCL22 |
CCL22, A-152E5.1, MDC, SCYA22: Small-inducible cytokine A22 precursor |
TSHR |
IPI00386365 |
0.557 |
Evidence |
|
| CCL22 |
CCL22, A-152E5.1, MDC, SCYA22: Small-inducible cytokine A22 precursor |
CCR5 |
CCR5: CCR5 receptor (Fragment) |
0.557 |
Evidence |
|
| CCL22 |
CCL22, A-152E5.1, MDC, SCYA22: Small-inducible cytokine A22 precursor |
GPR23 |
LPA4, GPR23, P2RY9: Lysophosphatidic acid receptor 4 |
0.557 |
Evidence |
|
| CCL22 |
CCL22, A-152E5.1, MDC, SCYA22: Small-inducible cytokine A22 precursor |
CXCR4 |
CXCR4: C-X-C chemokine receptor type 4 |
0.557 |
Evidence |
|
| CCL22 |
CCL22, A-152E5.1, MDC, SCYA22: Small-inducible cytokine A22 precursor |
F2RL1 |
F2RL1, GPR11, PAR2: Proteinase-activated receptor 2 precursor |
0.557 |
Evidence |
|
| CCL22 |
CCL22, A-152E5.1, MDC, SCYA22: Small-inducible cytokine A22 precursor |
HTR6 |
HTR6: 5-hydroxytryptamine receptor 6 |
0.557 |
Evidence |
|
| CCL22 |
CCL22, A-152E5.1, MDC, SCYA22: Small-inducible cytokine A22 precursor |
TRHR |
TRHR: Thyrotropin-releasing hormone receptor |
0.557 |
Evidence |
|
| CCL22 |
CCL22, A-152E5.1, MDC, SCYA22: Small-inducible cytokine A22 precursor |
SSTR3 |
SSTR3: Somatostatin receptor type 3 |
0.557 |
Evidence |
|
| CCL22 |
CCL22, A-152E5.1, MDC, SCYA22: Small-inducible cytokine A22 precursor |
MC4R |
MC4R: Melanocortin receptor 4 |
0.557 |
Evidence |
|
| CCL22 |
CCL22, A-152E5.1, MDC, SCYA22: Small-inducible cytokine A22 precursor |
HTR2C |
HTR2C, HTR1C: 5-hydroxytryptamine receptor 2C |
0.557 |
Evidence |
|
| CCL22 |
CCL22, A-152E5.1, MDC, SCYA22: Small-inducible cytokine A22 precursor |
F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
0.557 |
Evidence |
|
| CCL22 |
CCL22, A-152E5.1, MDC, SCYA22: Small-inducible cytokine A22 precursor |
FPRL1 |
FPRL1, FPR2, FPRH1, LXA4R: FMLP-related receptor I |
0.557 |
Evidence |
|
| CCL22 |
CCL22, A-152E5.1, MDC, SCYA22: Small-inducible cytokine A22 precursor |
IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
0.557 |
Evidence |
|
| CCL22 |
CCL22, A-152E5.1, MDC, SCYA22: Small-inducible cytokine A22 precursor |
C5AR1 |
C5AR1, C5AR, C5R1: C5a anaphylatoxin chemotactic receptor |
0.557 |
Evidence |
|
| CCL22 |
CCL22, A-152E5.1, MDC, SCYA22: Small-inducible cytokine A22 precursor |
DRD1 |
DRD1: D(1A) dopamine receptor |
0.557 |
Evidence |
|
| CCL22 |
CCL22, A-152E5.1, MDC, SCYA22: Small-inducible cytokine A22 precursor |
FPR1 |
FPR1: fMet-Leu-Phe receptor |
0.557 |
Evidence |
|
| CCL22 |
CCL22, A-152E5.1, MDC, SCYA22: Small-inducible cytokine A22 precursor |
EDG1 |
EDG1: Sphingosine 1-phosphate receptor Edg-1 |
0.557 |
Evidence |
|
| CCL22 |
CCL22, A-152E5.1, MDC, SCYA22: Small-inducible cytokine A22 precursor |
TACR2 |
TACR2, NK2R, NKNAR, TAC2R: Substance-K receptor |
0.557 |
Evidence |
|
| CCL22 |
CCL22, A-152E5.1, MDC, SCYA22: Small-inducible cytokine A22 precursor |
ADRB2 |
ADRB2, ADRB2R, B2AR: Beta-2 adrenergic receptor |
0.557 |
Evidence |
|
| CCL21 |
CCL21, SCYA21, UNQ784/PRO1600: Small-inducible cytokine A21 precursor |
GPR23 |
LPA4, GPR23, P2RY9: Lysophosphatidic acid receptor 4 |
0.557 |
Evidence |
|